KEI statement on GSK’s announcement of policies to expand access to patented medicines
GSK has made a major announcement of new policies to expand access to its patented medicines. A copy of the press statement is here. Continue Reading
Intellectual Property Rights
SCP 31: Upcoming WIPO review of existing research on patents and access to medical products and health technologies
As part of the work program of the Standing Committee on the Law of Patents (SCP), the secretariat of the World Intellectual Property Organization (WIPO) has been mandated to prepare a 40-50 page review of “existing research on patents and… Continue Reading
Transparency and delinkage embedded into the Human Rights Council’s agenda on access to medicines
On Thursday, 11 July 2019, the 41st session of the Human Rights Council (HRC) adopted, without a vote, resolution A/HRC/41/L.13, “Access to medicines and vaccines in the context of the right of the highest attainable standard of physical and mental… Continue Reading
Delinkage, TRIPS flexibilities, and alternative incentive frameworks emerge as flashpoints during Human Rights Council’s discussions on Access to Medicines and Vaccines
UPDATE: On 4 July 2019, the Core Group will submit a “TABLING REV 1” version of their resolution on “Access to medicines and vaccines in the context of the right of everyone to the enjoyment of the highest attainable standard… Continue Reading
Human Rights Council (2019): Core Group circulates zero draft on access to medicines and vaccines
At the 41st session (24 June 2019 – 12 July 2019) of the Human Rights Council, a bloc of countries known as the the Core Group (Brazil, China, Egypt, Indonesia, India, Senegal, South Africa and Thailand) have circulated a resolution… Continue Reading
SCP 30: General statement of Knowledge Ecology International
On Monday, 24 June 2019, Knowledge Ecology International (KEI) delivered this opening statement at WIPO’s 30th Session of the Standing Committee on the Law of Patents (SCP). The Committee elected a new chair, Sarah Whitehead, United Kingdom of Great Britain… Continue Reading
WHA72: Portuguese Minister of Health, Marta Temido, underscores strong support for the WHO transparency resolution
On Monday, 20 May 2019, the Republic of Korea, Italy, Costa Rica, Greece, Indonesia, Italy, Mexico, Mongolia, Netherlands, Portugal, Republic of Korea, Saudi Arabia, Spain, and Vietnam convened an official side event at the 72nd session of the World Health… Continue Reading
24 May 2019 – KEI panel discussion – Assessing the implications of the development of new cell and gene-based therapies (including CAR T and CRISPR): What role should WHO play?
On Friday, 24 May 2019, Knowledge Ecology International (KEI) will convene an expert panel, “Assessing the implications of developments in cell and gene-based therapies (including CAR T and CRISPR): What role should WHO should play?” from 12h30 to 14h30 in… Continue Reading
WIPO Broadcasting Treaty – Paving the way for a right for on-demand streaming services?
In April 2019, the World Intellectual Property Organization (WIPO) published a new version (SCCR/38/10) of the WIPO Treaty for the Protection of Broadcasting Organizations. Currently, the proposed treaty anticipates the scope of application to include new beneficiaries such as on-demand… Continue Reading
Selected bills introduced in the U.S. Congress that include drug price or R&D transparency provisions
116th Congress Senate S.102 – Prescription Drug Price Relief Act of 2019 S.366 – FLAT Prices Act S.378 – Stop Price Gouging Act S.474 – Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 S.476 – Creating… Continue Reading
Compulsory licensing in the context of U.S. injunction cases involving non-medical technologies
Selected cases where infringement exists, but a federal judge permits ongoing infringement. 2006. June 14: z4 Techs., Inc. v. Microsoft Corp., 434 F. Supp. 2d 437, 439 (E.D. Tex. 2006) Patents 6,044,471 and 6,785,825 disclose methods for limiting the unauthorized… Continue Reading